Boryung Corporation
003850 | KO
Overview
Corporate Details
- ISIN(s):
- KR7003850005
- LEI:
- Country:
- South Korea
- Address:
- 서울 종로구 원남동 보령빌딩 66-21, 종로구
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 3.8 MB | ||
| 2025-08-08 00:00 |
Governance Information
공정거래자율준수프로그램운영현황(안내공시)
|
Korean | 17.3 KB | ||
| 2025-07-31 00:00 |
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
|
Korean | 15.1 KB | ||
| 2025-06-12 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 138.9 KB | ||
| 2025-06-12 00:00 |
Transaction in Own Shares
자기주식처분결과보고서
|
Korean | 16.6 KB | ||
| 2025-06-12 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-06-12 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-06-05 00:00 |
Transaction in Own Shares
주요사항보고서(자기주식처분결정)
|
Korean | 29.0 KB | ||
| 2025-06-02 00:00 |
Environmental & Social Information
지속가능경영보고서등관련사항(자율공시)
|
Korean | 10.2 KB | ||
| 2025-06-02 00:00 |
Governance Information
기업지배구조보고서공시
|
Korean | 770.4 KB | ||
| 2025-05-23 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 27.4 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 2.2 MB | ||
| 2025-04-29 00:00 |
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
|
Korean | 15.0 KB | ||
| 2025-04-25 00:00 |
Legal Proceedings Report
투자판단관련주요경영사항
|
Korean | 16.8 KB | ||
| 2025-04-23 00:00 |
Prospectus
투자설명서
|
Korean | 4.0 MB |
Automate Your Workflow. Get a real-time feed of all Boryung Corporation filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Boryung Corporation
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Boryung Corporation via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Develops affordable biosimilars for serious diseases using patented, high-yield production tech.
Sweden
XBRANE
Sweden
XBRANE
Develops serum-free media & automated systems for cell therapy & regenerative medicine.
South Korea
373110
South Korea
373110
Engineering antibody & cytokine therapeutics for cancer and autoimmune diseases via its XmAb platform.
United States of America
XNCR
United States of America
XNCR
Advancing DNase & CAR T immune-oncology platforms to treat hard-to-treat cancers.
United States of America
XBIO
United States of America
XBIO
A neuroscience biopharma developing novel therapeutics for epilepsy and depression.
United States of America
XENE
United States of America
XENE
Develops ready-to-use injectable drugs for chronic, metabolic, and rare diseases.
United States of America
XERS
United States of America
XERS
Developing late-stage, uric acid-lowering therapies for gout and progressive kidney disease.
United States of America
XRTX
United States of America
XRTX
Develops improved cancer drugs (PKIs) using patented tech to circumvent secondary patents.
Sweden
XSPRAY
Sweden
XSPRAY
Acquires and develops late-stage drugs for unmet medical needs, focusing on autoimmune diseases.
Israel
XTLB
Israel
XTLB
